News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
LIFE SCIENCES OPPORTUNITIES FUND II LP
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/16/2020 |
4
| LIFE SCIENCES OPPORTUNITIES FUND INSTITTUTIONAL II LP (10% Owner) has filed a Form 4 on Teligent, Inc.|
Txns:
| Sold 74,020 shares
@ $2.2565, valued at
$167k
Sold 13,251 shares
@ $2.2459, valued at
$29.8k
Sold 102,962 shares
@ $1.6615, valued at
$171.1k
Sold 18,432 shares
@ $1.6569, valued at
$30.5k
Sold 84,816 shares
@ $1.1336, valued at
$96.1k
Sold 15,184 shares
@ $1.1266, valued at
$17.1k
Sold 475,512 shares
@ $1.2435, valued at
$591.3k
Sold 85,106 shares
@ $1.2478, valued at
$106.2k
|
|
| 03/09/2015 |
SC 13D/A
| LIFE SCIENCES OPPORTUNITIES FUND II LP reports a 18.9% stake in IGI Laboratories, Inc. |
| 03/06/2015 |
4
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 4 on IGI LABORATORIES, INC|
Txns:
| Sold 303,680 shares
@ $9.95, valued at
$3M
Sold 1,696,320 shares
@ $9.95, valued at
$16.9M
|
|
| 02/13/2015 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 09/04/2014 |
SC 13D/A
| LIFE SCIENCES OPPORTUNITIES FUND II LP reports a 24.6% stake in IGI Laboratories, Inc. |
| 09/04/2014 |
4
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 4 on IGI LABORATORIES, INC|
Txns:
| Sold 303,500 shares
@ $6.45, valued at
$2M
Sold 1,696,500 shares
@ $6.45, valued at
$10.9M
|
|
| 08/29/2014 |
SC 13D/A
| LIFE SCIENCES OPPORTUNITIES FUND II LP reports a 26.6% stake in IGI Laboratories, Inc. |
| 08/29/2014 |
4
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 4 on IGI LABORATORIES, INC|
Txns:
| Sold 455,257 shares
@ $6.2, valued at
$2.8M
Sold 2,544,743 shares
@ $6.2, valued at
$15.8M
|
|
| 07/08/2014 |
SC 13D/A
| LIFE SCIENCES OPPORTUNITIES FUND II LP reports a 32.3% stake in IGI Laboratories, Inc. |
| 06/05/2014 |
4
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 4 on BIOJECT MEDICAL TECHNOLOGIES INC|
Txns:
| Converted 316,884 shares
@ $0
Converted 325,908 shares
@ $0
Converted 1,482,067 shares
@ $0
Converted 1,770,073 shares
@ $0
Converted 1,820,483 shares
@ $0
Converted 8,290,002 shares
@ $0
Converted 207,255 shares
@ $0
Converted 656,306 shares
@ $0
Converted 316,884 convertible preferred
@ $1.15, valued at
$364.4k
Converted 325,908 convertible preferred
@ $1.37, valued at
$446.5k
Converted 14,821 convertible preferred
@ $0.13, valued at
$1.9k
|
|
| 06/03/2014 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/19/2013 |
4
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 4 on BIOJECT MEDICAL TECHNOLOGIES INC|
Txns:
| Acquired 2,732 preferred shares
@ $13, valued at
$35.5k
Acquired 15,258 preferred shares
@ $13, valued at
$198.4k
|
|
| 02/19/2013 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities |
| 02/19/2013 |
4
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 4 on BIOJECT MEDICAL TECHNOLOGIES INC|
Txns:
| Acquired 22,328 convertible preferred
@ $1.37, valued at
$30.6k
Acquired 124,720 convertible preferred
@ $1.37, valued at
$170.9k
Acquired 24,114 convertible preferred
@ $1.37, valued at
$33k
Acquired 134,698 convertible preferred
@ $1.37, valued at
$184.5k
Acquired 14,215 options to buy
@ $137, valued at
$1.9M
Acquired 45,104 convertible preferred
@ $1.37, valued at
$61.8k
Acquired 15,352 convertible preferred
@ $1.37, valued at
$21k
Acquired 48,615 convertible preferred
@ $1.37, valued at
$66.6k
|
|
| 02/15/2013 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 02/06/2013 |
4
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 4 on BIOJECT MEDICAL TECHNOLOGIES INC|
Txns:
| Bought 11,388 preferred shares
@ $0.035, valued at
$398.6
Bought 63,612 preferred shares
@ $0.035, valued at
$2.2k
|
|
| 02/05/2013 |
4
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 4 on BIOJECT MEDICAL TECHNOLOGIES INC|
Txns:
| Acquired 9,665 preferred shares
@ $13, valued at
$125.6k
Acquired 44,323 preferred shares
@ $13, valued at
$576.2k
Disposed of convertible notes
@ $0 |
|
| 12/11/2012 |
SC 13D/A
| LIFE SCIENCES OPPORTUNITIES FUND II LP reports a 41.9% stake in IGI Laboratories, Inc. |
| 08/24/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 08/24/2010 |
4
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 4 on IGI LABORATORIES, INC|
Txns:
| Converted 2,382,167 shares
@ $0
Converted 13,310,657 shares
@ $0
Converted 153 convertible preferred
@ $0
Converted 854 convertible preferred
@ $0 |
|
| 04/13/2010 |
4
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 4 on IGI LABORATORIES, INC|
Txns:
| Bought 573 convertible preferred
@ $0
Bought 102 convertible preferred
@ $0 |
|
| 04/08/2010 |
SC 13D/A
| Form SC 13D - General statement of acquisition of beneficial ownership [amend] |
| 05/19/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/19/2009 |
SC 13D/A
| LIFE SCIENCES OPPORTUNITIES FUND II LP reports a 47.7% stake in IGI Laboratories, Inc. |
| 04/02/2009 |
3/A
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 3/A on IGI INC |
| 03/24/2009 |
3
| LIFE SCIENCES OPPORTUNITIES FUND II LP (10% Owner) has filed a Form 3 on IGI INC |
| 03/24/2009 |
SC 13D
| Form SC 13D -- General statement of acquisition of beneficial ownership |
| 11/07/2003 |
REGDEX
| Form REGDEX -- Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933] Effectiveness Date: 2003-11-06 |
|
|